| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |